Jasper Therapeutics Announces Briquilimab Development Program in Asthma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/29/2026

1. WDAY
2. ESTC
3. MRVL
4. AFRM
5. RBRK
6. S
7. GAP
8. DG
9. ULTA
10. NVDA

Go back to Jasper Therapeutics Announces Briquilimab Development Program in Asthma
(NASDAQ: JSPR) Delayed: 0.70 --0 (-0%)
Previous Close $0.70    52 Week High $ 
Open $0.71    52 Week Low $ 
Day High $0.71    P/E N/A 
Day Low $0.66    EPS $ 
Volume 267,424